Close Menu

Wellcome Sanger Institute

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.

Infants born vaginally had gut microbiomes enriched with commensal bacteria, while those born by caesarian section harbored hospital-associated bacteria.

Illumina is contributing reagents for 100 genomes worth of short-read sequence data to help scientists generate 100 new high-quality reference genomes.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.

Single-cell transcriptomic profiles for more than 1,700 malaria-causing Plasmodium berghei parasites revealed gene expression patterns that differ by parasite stage.

The NAM, NAS, and Royal Society have formed a commission to develop a framework on the proper use of genome editing, and convened its first meeting in Washington, DC, this week.

An analysis of more than 900 C. difficile isolates uncovered four phylogenetic lineages, including three lineages in a clade showing recent positive selection on infection-related genes.

Through a transcriptomic analysis, the researchers developed a catalog of gene expression with the olfactory mucosa of half a dozen mammals.

Researchers sequenced more than 1,700 Klebsiella pneumoniae isolates from European hospitals to better understand the spread of drug-resistant strains.

The grant recipients will receive up to $5 million each and are led by scientists at institutions including Harvard Medical School and the Cleveland Clinic.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.